Last reviewed · How we verify
GT20029 Gel
At a glance
| Generic name | GT20029 Gel |
|---|---|
| Sponsor | Suzhou Kintor Pharmaceutical Inc, |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects (PHASE1)
- Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GT20029 Gel CI brief — competitive landscape report
- GT20029 Gel updates RSS · CI watch RSS
- Suzhou Kintor Pharmaceutical Inc, portfolio CI